Tuesday, October 19, 2021


WTO again fails to agree on Covid vaccine patent waiver

South Africa and India have called for intellectual property rights to be temporarily lifted for Covid-19 vaccines during the pandemic but the idea has met with fierce opposition from pharmaceutical giants and their host countries.

G20 trade ministers back fairer Covid vaccine distribution

While more than six billion vaccine doses have been produced and administered worldwide, only 1.4% of people in poor countries have been fully vaccinated, compared to 58% in rich countries.

A year after Covid vaccine waiver proposal, WTO talks deadlocked

More than 100 countries backing the waiver say it will help save lives by allowing developing countries to produce Covid-19 vaccines.

Jurang ketaksamaan kadar vaksinasi jejas kebangkitan ekonomi global, kata WTO

Perkara ini berlaku terutamanya di negara-negara berpendapatan rendah, yang merekodkan hanya 1% populasi menerima satu dos vaksin.

WTO says disparities in vaccine rates can hit economic rebound

Failure to ensure global access to vaccines poses a serious threat to the global economy and to public health, it says.

Still no agreement at WTO on proposal for Covid jab IP waiver

The WTO says all countries agree on the need to ramp up production quickly, but disagree on how best to achieve the goal.

EU not backing Covid vaccine patent suspension at WTO

It is calling for compulsory licensing deals rather than suspending patents.

EU, UK raise doubts about Covid patent waiver

Agreements at the WTO require the consensus backing of all 164 member states.

Renewed calls for PM to back waiver on Covid-19 patents following US move

NGOs and advocacy groups say the local pharmaceutical industry can help but need the freedom to operate that a WTO waiver could speed up.

US backs plan to waive Covid-19 vaccine patents

US trade representative says while intellectual property rights for businesses are important, Washington 'supports the waiver of those protections for Covid-19 vaccines' in order to end the pandemic.

Supply chain strain threatening mass scale-up of Covid-19 jabs

Vaccine manufacturers expect to be able to produce some 10 billion doses of various Covid-19 vaccines this year – double the manufacturing capacity for all vaccines combined in 2019.

It’s not just about patent rights, expert says on ways to make Covid jabs cheaper

India's Serum Institute offers a good example of overcoming the problem of vaccine exclusivity during the current health emergency.

Other News